There are moments when humanity encounters something so unusual that the first reaction is disbelief.
Medicine has repeatedly experienced such moments.
Conditions once considered extraordinarily rare have eventually become documented, classified, studied, and treated. What initially appears impossible may turn out to be a biological variation that medicine simply has limited experience with.
One such example is diphallia, or penile duplication—a rare congenital condition in which a male infant is born with two penile structures. Medical literature has documented cases ranging from partial duplication to complete duplication involving the penis, urethra, and, in some cases, associated urinary or other anatomical abnormalities. The condition is estimated to occur in approximately one in five to six million births.
That rarity, however, should not become a reason for society to be unprepared.
The Future Requires Preparedness, Not Fear
When speaking about unusual congenital conditions, we must be careful.
There is currently no scientific basis for claiming that penile duplication is about to become common or that its incidence is necessarily increasing. A vision, prediction, personal conviction, or unusual observation cannot substitute for epidemiological evidence.
But there is an important distinction between predicting an increase and preparing responsibly for the possibility of encountering more unusual presentations.
The medical community should always be prepared for biological variation.
If an unusual congenital condition is encountered, the correct response should not be panic, ridicule, superstition, concealment, or immediate assumptions about its cause.
The response should be:
Observe. Document. Investigate. Understand. Treat where necessary. Protect the child. Support the family.
That is how medicine advances.
When the Unusual Becomes a Patient
A child born with an unusual anatomical condition is first and foremost a child.
The abnormality should not become the child's identity.
This is particularly important when the condition involves visible genital differences. Such children may become vulnerable to shame, social isolation, exploitation, bullying, religious interpretations, or sensational public attention.
Medical professionals therefore have two responsibilities.
The first is clinical: determine exactly what anatomical structures are present and whether other systems are affected.
The second is human: protect the dignity and psychological wellbeing of the child and family.
Published medical reviews demonstrate why thorough assessment matters. Diphallia can occur alongside abnormalities involving the urinary system, bladder, gastrointestinal tract, skeletal structures, and other organs. Consequently, discovering duplication of the external genitalia may require investigation beyond what is immediately visible.
The visible feature may only be the beginning of the clinical picture.
Medicine Must Look Beyond What the Eye Sees
One of the dangers of rare congenital conditions is that observers may focus entirely on the unusual external appearance.
But medicine must ask deeper questions.
Are there two functioning urethras?
How is the urinary system structured?
Is the bladder duplicated or otherwise abnormal?
Are the reproductive organs normally developed?
Are there associated gastrointestinal or skeletal abnormalities?
Is there a cardiovascular or renal abnormality?
What is the child's long-term functional prognosis?
What treatment, if any, is necessary?
These are medical questions—not questions for public speculation.
The literature already demonstrates that patients with diphallia can have markedly different anatomical configurations, which is why individualized investigation and treatment are necessary.
The Need for Better Surveillance
If medicine is to recognize unusual congenital conditions properly, it needs good records.
A condition that occurs once in millions of births cannot be understood through isolated anecdotes.
It requires systematic documentation.
Hospitals should record unusual congenital anomalies accurately. Specialists should have mechanisms for reporting rare presentations. Researchers should be able to compare cases across countries. Public-health authorities should be able to determine whether an apparent increase represents a genuine epidemiological change or simply improved detection and reporting.
This is already consistent with WHO's approach to congenital anomalies. WHO recommends surveillance systems capable of monitoring trends, identifying clusters, referring affected infants to appropriate services, supporting research, and evaluating prevention programs.
This becomes especially important in countries where congenital-anomaly data may be incomplete.
Preparing Communities
Medical preparation alone is not enough.
A child can receive excellent surgery and still suffer enormously if the surrounding community treats the child as a curiosity.
Communities must therefore learn an important principle:
Difference is not permission for humiliation.
Parents should not be blamed automatically.
The child should not be called cursed.
The condition should not automatically be interpreted as evidence of parental wrongdoing, spiritual failure, witchcraft, punishment, or supernatural contamination.
Faith communities may have their own interpretations, but those interpretations should never replace appropriate medical assessment or become a reason to deny a child healthcare.
Likewise, medical professionals should not dismiss the family's cultural or spiritual concerns with contempt. They should communicate carefully, respectfully, and scientifically.
The objective should be cooperation rather than confrontation.
Preparing African Health Systems
This conversation is particularly important for health systems with limited specialist resources.
WHO notes that more than 90% of children born with congenital conditions are in low- and middle-income countries and emphasizes strengthening screening, diagnosis, treatment, surveillance, and long-term care.
Preparation therefore means more than building sophisticated hospitals.
It means developing referral pathways.
It means training paediatricians, neonatologists, paediatric surgeons, urologists, radiologists, geneticists, nurses, psychologists, and other relevant professionals.
It means ensuring that a rural or district hospital encountering an extremely unusual newborn knows where to refer the child and how to preserve accurate clinical information before referral.
It means building databases capable of identifying rare congenital presentations.
And it means making sure that families are not abandoned simply because their child's condition falls outside ordinary clinical experience.
What If We Begin Seeing More Unusual Cases?
If, in the future, clinicians encounter a number of unusual congenital presentations that appear to resemble one another, the appropriate response should be scientific investigation.
Not immediate conclusions.
Researchers should examine:
- the number of cases;
- geographic distribution;
- maternal and paternal histories;
- prenatal exposures;
- medications and environmental exposures;
- infections;
- nutritional factors;
- genetic findings;
- family history;
- pregnancy complications;
- anatomical patterns;
- associated congenital abnormalities; and
- changes in detection and reporting practices.
Only through systematic evidence could researchers determine whether an apparent pattern represents coincidence, improved recognition, a reporting effect, or a genuine epidemiological change.
WHO emphasizes that the causes of many congenital disorders remain unknown and can involve complex interactions among genetic, infectious, nutritional, environmental, and other factors.
Therefore, unusual observations should become questions for research, not premature explanations.
A Different Kind of Preparedness
Perhaps the greatest preparation is not technological.
It is intellectual humility.
Medicine must be confident enough to say:
“We have seen this before, but it is extremely rare.”
And also:
“We have never seen this exact presentation before, so we need to investigate it carefully.”
Those two statements are signs of scientific maturity.
The danger comes when either society or medicine assumes that everything unusual must be impossible simply because it is unfamiliar.
Human biology is extraordinarily complex.
There will always be variations that challenge existing categories.
The responsibility of medicine is not to fear those variations.
It is to understand them.
The Child Must Come First
Whatever the future brings, one principle should remain non-negotiable:
The child must never become secondary to the phenomenon.
If a newborn presents with an extraordinary anatomical condition, the first questions should concern the child's health, safety, function, development, and dignity.
The child is not a spectacle.
The child is not a prophecy.
The child is not a community symbol.
The child is not evidence for somebody else's theory.
The child is a human being who requires competent medical care and protection.
Preparing Before the Next Rare Case
Perhaps we should not wait for an unusual case to expose weaknesses in our health systems.
We can prepare now.
We can strengthen congenital-anomaly surveillance.
We can improve neonatal examination and referral systems.
We can increase specialist training.
We can develop ethical protocols for rare anatomical conditions.
We can improve genetic and imaging capacity where appropriate.
We can establish multidisciplinary teams.
We can protect patient confidentiality.
We can educate communities against stigma.
And we can create research networks capable of studying extremely rare conditions when they appear.
The World Health Organization has already emphasized the importance of surveillance, diagnostic capacity, research, and long-term care for congenital anomalies, including in low- and middle-income countries.
The question, therefore, is not whether society should become frightened about rare biological conditions.
It is whether society is prepared to respond intelligently when the unexpected appears.
The Warning Is Not the Diagnosis
There is a profound difference between saying:
“This may happen.”
and saying:
“This will happen.”
The first can encourage preparation.
The second requires evidence.
If unusual congenital presentations become more frequently documented in the future, medicine should be ready to recognize them without disbelief and investigate them without prejudice.
And if they do not increase, the preparation will not have been wasted. The same surveillance systems, specialist capacity, research networks, and community education will help children with many other congenital conditions.
The future does not need our fear.
It needs our preparedness.
And when the unusual finally appears before us, our first response should not be:
“How can this be possible?”
It should be:
“How do we understand it, how do we protect this child, and what can this teach medicine?”
Ibrahim Mahama took me abroad for surgery after Lordina’s intervention – Dzokoto
President Mahama to Walk the Runway on November 7
Heavy fighting, internet disruption as Ethiopia conflict rages
Saudi reports fresh Houthi attacks as France pledges to defend key oil port
Israel must win 'because we’ve got no other choice’, PM Netanyahu tells UN
Mahama reiterates Ghana's commitment to two-state solution to Palestine-Israel c...
Ablakwa calls for Return of African Artefacts held abroad
Madina MP Francis-Xavier Sosu reportedly collapses while speaking at GIMPA
Kumasi drivers, passengers react to 8% transport fare increase
Mahama petitioned to halt Sentuo Airport Garden City construction after sod cutt...
